Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03446937Completed
Randomised, double-blind trial in neonatal respiratory distress syndrome (NRDS) comparing Dexamethasone, Betamethasone and Placebo (3 arms). Primary endpoint: Neonatal Respiratory Distress Syndrome at 72 hours. Started Dec 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03446937.